Prostatic artery embolization is a relatively new nonsurgical technique for treating benign prostatic hypertrophy, or BPH. Its usage is still in its infancy, but there is growing research into its effectiveness. However, a number of limitations exist, so the procedure is still considered experimental. The procedure is generally performed via a small puncture in the groin or wrist. A catheter is then inserted through the artery and advanced to the prostate. This is an alternative treatment for surgical procedures which is performed through interventional radiology. In a prostatic artery embolization procedure, the interventional radiologist shrinks the prostate by treating blood vessels in the prostate through an incision in the patient’s upper thigh.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4108
Global Prostatic Artery Embolization Market- Drivers
Prostatic artery embolization is consider as more effective than prostate gland enlargement surgery. It has several advantages compared to surgical procedures such as fast recovery and less morbidity. Moreover, it is short invasive treatment than traditional prostatic treatment. Thus, various healthcare facilities are implementing prostatic artery embolization treatment because of its efficiency and safety. According to the University of California and San Francisco (UCSF), Department of Radiology and Bio-medical Imaging, there is a growing adoption of prostatic artery embolization procedures among physicians in the U.S. due to the procedure’s less invasive nature compared to traditional surgical procedures. These factors are expected to support global prostatic artery embolization market growth during the forecast period.
Global Prostatic Artery Embolization Market- Impact of COVID-19
The COVID-19 pandemic has impacted growth of various markets, and it is also expected to hinder the growth of the global prostatic artery embolization market. Moreover, implementation of nationwide lockdown across several countries and safety precautions suggested by World Health Organization to curb the spread of COVID-19 while performing surgical procedures it has become very difficult to conduct surgical procedures in patients.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4108
Global Prostatic Artery Embolization Market- Restraints
Side-effects associated with prostatic artery embolization procedure such as ‘Post-PAE Syndrome’ in patients is expected to hinder growth of the market. In Post-PAE syndrome, patients may experience pelvic pain, nausea, and frequent urination which may refrain them from opting for this treatment option. Moreover, according to U.S National Library of Medicine, prostatic artery embolization procedures involves use of ionization radiation with dose range of approximately 47 mSv, which is roughly equivalent to increase lifetime cancer risk in patient population with average age of 65 in men.
Global Prostatic Artery Embolization Market- Regional Analysis
Regionally, the global prostatic artery embolization market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The North America Prostatic artery embolization market is estimated to exhibit significant growth owing to increasing focus of pharmaceutical medical device companies on new product development. For instance, in 2017 Merit Medical Systems Inc. received an approval for its Merit’s Embosphere from the Food Drug Administration (FDA) for Prostatic artery embolization, a non-surgical treatment for men who suffer from Benign Prostate Hyperplasia (BPH).
Moreover, the Europe Prostatic artery embolization market is expected to witness significant growth owing to various actions taken by regulatory bodies across the region. For instance, in 2018, the United Kingdom National Institute of Health and Care Excellence, which provides guidance and advice related to health, stated that the prostatic artery embolization procedure is safe and provides clinically stable results in treatment of prostate enlargement due to Benign Prostate Hyperplasia (BPH).
Global Prostatic Artery Embolization Market- Competitive Landscape
Mentice AB, Merit Medical Systems, Inc, Boston Scientific Corporation, Siemens Healthineers AG, GE Healthcare, Terumo Corporation, Embolx, Inc., and QXMedical, LLC.
Key Developments-
- In 2018, Embolx, Inc., a medical device company, announced CE certification for its next generation of sniper balloon occlusion micro-catheters for treatment of enlarged prostate and cancerous tumors.
- In 2019, QX Medicals, a medical device company, acquired the rights of bioresorbable embolic technology developed by researchers at the University of Minnesota. This bioresorbable embolic technology is are used by interventional radiologist for prostatic artery embolization.
Global Prostatic Artery Embolization Market- Taxonomy
- By Product Type-
- Microspheres
- Micro-catheters
- Guidewires
- By End User-
- Hospitals
- Ambulatory Surgical Centres
- Speciality Clinics
- By Region-
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Direct Buy This Premium Research Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/4108
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Prostatic Artery Embolization Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Prostatic Artery Embolization Industry Impact
Chapter 2 Global Prostatic Artery Embolization Competition by Types, Applications, and Top Regions and Countries
2.1 Global Prostatic Artery Embolization (Volume and Value) by Type
2.3 Global Prostatic Artery Embolization (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Prostatic Artery Embolization Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Prostatic Artery Embolization Market Analysis
Chapter 6 East Asia Prostatic Artery Embolization Market Analysis
Chapter 7 Europe Prostatic Artery Embolization Market Analysis
Chapter 8 South Asia Prostatic Artery Embolization Market Analysis
Chapter 9 Southeast Asia Prostatic Artery Embolization Market Analysis
Chapter 10 Middle East Prostatic Artery Embolization Market Analysis
Chapter 11 Africa Prostatic Artery Embolization Market Analysis
Chapter 12 Oceania Prostatic Artery Embolization Market Analysis
Chapter 13 South America Prostatic Artery Embolization Market Analysis
Chapter 14 Company Profiles and Key Figures in Prostatic Artery Embolization Business
Chapter 15 Global Prostatic Artery Embolization Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com